Faris Salama

Head of Business Development, Export and Strategic PartnershipFull Time

• Job Details:NOV.2019 TO PRESENT HEAD OF BUSINESS DEVELOPMENT AND STRATEGIC PARTNERSHIP ZETA PHARMA - CAIRO Strategic Management Plan: • Created a five-year strategic plan with plausible assumptions about future business trends with horizontal and vertical integration strategies and targeting: o First 1 billion L.E revenue. o Top 5th rank in acid-related disorders market aimed at capturing 0.5 billion L.E. o #1 rank in oral antidiabetic SGLT2 market and top 10th rank in CVS market. o Planned to rank the company among the top 50 pharmaceutical companies in Egypt in 2022. …Continued… Project Management: • Negotiated and contracted with the European bank (EBRD) to facilitate key project that qualified Zeta’s factory to obtain EMA GMP accreditation within two years and coordinated cross-functional team from the factory, supply chain, regulatory, finance, and business development teams to achieve the following milestones: o Finished first phase of jap report analysis by 2021 o Negotiated and got approval to extend the project an extra one year due to COVID-19 o Aim to finish the first CTD file registration in Europe and get Zeta factory mock inspection by 2022 o Aim to get EMA authority inspection and EMA certification by 2023 B2B Partnership: • Orchestrated global importers’ pipeline during CPHI exhibition in Frankfurt-2019. • Devised portfolio of international suppliers’ partnerships that delivered unique health solutions covering unmet needs across the market during Vitafoods-2019 from the following countries: o France: Nutriset • Italy: Gnosis •Spain: AB-Biotic •Canada: Lallemand Patients Centricity: • Introduced a lifetime patient activation program with a strong focus on patient's willingness and capacity to take independent actions to manage health and care, including: o Self-monitoring tools and periodic-patient monitoring at doctor visits through point of care. o Engaged 1500 patients through social media campaigns and mobile apps. o Initiated corporate social responsibility CSR and supported more patients’ access to new medicine through 40% price reduction. https://bit.ly/3IqKDdy Growth Revenue Plan: • Drove revenue growth through e-commerce business development: o Won contracts with Jumia and Amazon to sell the company’s food supplements through platforms. o Designed eCommerce website and mobile app to increase sales of supplements by 1 million Q1-2022 o https://dozova.com/public/en o https://bit.ly/3kmeOZh

Market Access ManagerFull Time

• Job Details:MARCH 2017 – OCT.2019 MARKET ACCESS MANAGER ZETA PHARMA, CAIRO Hepatitis C Project Initiative: ● Developed and executed through cross-functional alignment, the strategic HCV screening project with MOH authority build and maintain relationships with C-level executives there, and politicians that established Zeta as a strategic preferred partner and a key player in National Virus-C, eradication project. Pharmacoeconomic files: ● Developed pharmacoeconomic files and gained target pricing, for Zeta’s new products. Key Accounts Access: ● Directly manage the full sales cycle from prospect creation, value proposition, and deal closure that awarded us many strategic tenders: as anti-coagulant (Elimbosis) in MOH tender and, established strategic key accounts pipeline to access new segments in the local market (tenders, private health insurances, hospitals) Business Development ● Exported Zeta’s HCV portfolio to Ukraine & Armenia. ● Contracted to export Zeta’s product to Yemen and Gaza. ● Preparing for an export agreement with agents in Sudan, Iraq, Kenya, Nigeria, Ecuador Stakeholders Prioritization: ● Developed a fast-track project with regulatory affairs team seizing the opportunity of the ministerial decree no. 645 to accelerate registration and launching of most potential new products to fulfil the capacity of Zeta manufacture facility in SADAT city that launched by Q4-2021.

Cardiovascular Business Unit ManagerFull Time

• Job Details:Created business plan and strategy: ● Established the strategic direction to successfully launching the Cardiovascular business unit in 2008 including the creation of marketing plans and sales territories. ● Outcomes: Drove the growth of ADWA in the last 6 years with other lines from 5o to 172 Million LE Market Access & Business Development: ● Accessed major sectors all over Egypt, e.g., MOH, Army, Police, Universities, Egypt Air… etc. to secure strategic objectives achievement and future growth of the company. ● Targeted decision-making executives and carefully developed a level of credibility and trust, thereby growing brand loyalty. ● Outcomes: tripled annual key account sales volume within four years, growing sales from 10 LE million in 2009 to 30 LE million in 2013. Branded ADWIA's CVS product line: ● Directed the use of clinical trials for ADWIA products with KOL and published them in an international journal e.g., BMJ ● Initiated the participated in international conferences, DUBAI 2012 and Rhodes 2014 ● Initiated online marketing strategy using social media, e-mail marketing and blogs that create the company’s electronic communication, strategic blueprint, and led efforts to expand electronic interaction with customers. ● Outcomes: enhanced ADWIA’s reputation in the market.